Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Guidance On Nocturnal Home Hemodialysis Outlines Clinical Trial Needs

This article was originally published in The Gray Sheet

Executive Summary

An April 15 FDA guidance tells makers of nocturnal home hemodialysis systems what sorts of clinical trials they should perform to smooth the FDA pre-market clearance process

You may also be interested in...

Nightly Home Hemodialysis Gains First FDA Clearance

NxStage’s System One has received an expanded indication to treat patients overnight at home, which the company says improves quality of life.

Fresenius Acquires Renal Solutions, Next-Gen Home Dialysis Technology

The Nov. 29 acquisition of Renal Solutions Inc. (RSI) by Fresenius Medical Care is expected to give Fresenius a better hold on the home therapy market for kidney dialysis

FDA Panel Explores Nocturnal Hemodialysis Device, Trial Design

FDA's Gastroenterology & Urology Devices Panel emphasized the importance of human factors considerations for nocturnal hemodialysis devices during a June 8 meeting in Gaithersburg, Md

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts